Skip to content

Change the Future for Your Patients and Your Practice

Your patients will be impressed by the innovative technology of the headset. You and your team will appreciate how easily the AdaptDx Pro fits into your workflow. Everyone will welcome the peace of mind that comes from the early diagnosis and treatment of AMD.

Join the AMD Revolution

0476-bubble-text

Customer Success Stories

Our collection of customer success stories offers a look at some of the benefits of integrating dark adaptation testing into your patient care arsenal. Learn how your fellow eye care professionals utilize AdaptDx® technology as they work towards improved outcomes for their AMD patients as well as their practice.

0278-bookmark

Practical Opportunities in AMD Management

Whether you have a strong AMD program, are thinking of creating one, or need to up your game, our latest e-book, Practical Opportunities in AMD Management can provide you with updated information for how to improve patient outcomes and enhance practice revenue.

This 16-page e-book features industry experts who share their knowledge and experience in diagnosing and managing AMD. It also includes short vignettes from various optometrists that provide real-world examples of how they’ve implemented dark adaptation testing, as well as advice for their colleagues.

0029-blog

Read our Featured Blog

The Secret to Successful AMD Programs: 4 Steps for Standardization

Christine Akers, Practice Management Consultant at MacuLogix, gives 4 steps for standardization for a successful AMD Program.

Macular degeneration

Tour our Virtual Exhibit

Our interactive Virtual Exhibit allows you to meet the newest member of our team – Theia, the on-board technician for the AdaptDx Pro headset dark adaptometer. Theia will welcome you to the booth as you learn how tackling AMD can benefit your practice.

Explore the exhibit at your leisure – without any sales pressure – and see this amazing technology for yourself. When you are ready to learn more, just enter your ZIP Code into the laptop in the booth to find your Regional Sales Executive.

0479-bubble-video

Impaired Dark Adaptation: The Earliest Biomarker of AMD (video)

Before drusen are visible, an invisible layer of cholesterol builds up between the pigmented layer of the retina (RPE) and the elastic layer of Bruch’s membrane. These cholesterol deposits — basal laminar (BLamD) and basal linear (BLinD) — cause oxidative stress and inflammation, hindering nutrient transportation to photoreceptor cells. As photoreceptor cells die, it becomes harder for the eyes to adjust to the darkness, and night vision declines. This dark adaptation impairment is the first sign of AMD.

The cholesterol deposits grow over time. Where they become sufficiently thickened, the lesion becomes clinically detectable as a druse. The first visible druse caused by AMD is just the tip of the iceberg of these lesions.

Research has shown that impaired dark adaptation function can be detected at least three years before drusen are clinically evident, allowing for earlier diagnosis, treatment, and monitoring of AMD.

0475-bubble-question

Frequently Asked Questions

Find the answers to frequently asked questions about AMD, dark adaptation, and AdaptDx Pro testing.

Partner with MacuLogix

Implementation Expertise

Each AdaptDx Pro® purchase is supported by our AMD Excellence Program®️ to help you achieve your patient care and practice revenue goals.

Contact Our Sales Team

As the AMD Experts®, our sales team is here to answer your questions about the clinical and financial benefits of the AdaptDx Pro.